Wednesday, November 18, 2026
FDA GUIDANCENovember 05, 2026

FDA Grants Premarket Approval (PMA P120020): Supera Peripheral Stent System by Abbott Vascular (Idef Technologies Inc)

Affected Product:Supera Peripheral Stent System
Recalling Firm / Manufacturer:Abbott Vascular (Idef Technologies Inc)
Reference / Recall Number:P120020
Executive Summary:

FDA awards Class III Premarket Approval (PMA P120020) for Supera Peripheral Stent System sponsored by Abbott Vascular (Idef Technologies Inc).

The FDA Center for Devices and Radiological Health has granted Premarket Approval (PMA) for Supera Peripheral Stent System, classified as a Class III life-supporting or life-sustaining medical device.

PMA Approval Dossier

  • PMA Number: P120020
  • Applicant: Abbott Vascular (Idef Technologies Inc)
  • Device Designation: Supera Peripheral Stent System
  • Product Code: NIP
  • Decision Code: APPR

Approval was based on rigorous review of valid scientific evidence, including bench testing, animal studies, and human clinical trial outcomes establishing a reasonable assurance of safety and effectiveness.

Official Regulatory Docket:Open Agency Docket